Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) General Counsel Philip Mazzara sold 4,380 shares of the company’s stock in a transaction on Monday, November 16th. The shares were sold at an average price of $206.62, for a total transaction of $904,995.60. Following the completion of the sale, the general counsel directly owned 92,190 shares in the company, valued at $19,048,297.80. This trade represents a 4.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Astera Labs Price Performance
Shares of Astera Labs stock opened at $211.60 on Friday. The firm has a fifty day moving average price of $287.43 and a 200 day moving average price of $258.14. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48. The stock has a market cap of $36.98 billion, a PE ratio of 95.07 and a beta of 3.85.
Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.19 by $0.13. The company had revenue of $584.90 million for the quarter, compared to analyst estimates of $550.78 million. Astera Labs had a net margin of 29.64% and a return on equity of 25.35%. The firm’s revenue was up 153.6% on a year-over-year basis. During the same period in the prior year, the company earned $0.49 earnings per share. As a group, equities analysts expect that Astera Labs, Inc. will post 2.99 EPS for the current year.
Key Astera Labs News
Investors following ALAB have been watching these news items:
- Positive Sentiment: Astera’s expanded partnership with Hyve Solutions will integrate its Orion Compute Board, Fabric Tray and Link Board into Hyve’s Apex platform. The pre-validated components are intended to speed AI-rack deployment and offer enterprise and neocloud customers flexibility as accelerator needs grow. Article: Hyve Partnership Might Change the Case for Investing in Astera Labs
- Neutral Sentiment: Several executives, including the CEO, COO and general counsel, reported share sales from November 16. The filings say the transactions covered tax withholding on vested equity awards; executives retained substantial holdings, making the sales less clearly bearish than discretionary sales. Article: Astera Labs General Counsel Sells Stock
- Negative Sentiment: Technical commentary describes a shaky rebound, with the stock below its 50-day moving average. That may temper the positive earnings and partnership news and leave shares vulnerable to continued trading pressure. Article: Record Q3 Growth Meets a Shaky Rebound
Institutional Investors Weigh In On Astera Labs
Hedge funds and other institutional investors have recently modified their holdings of the company. Advisors Asset Management Inc. purchased a new stake in Astera Labs during the 3rd quarter worth about $624,000. Liontrust Investment Partners LLP increased its holdings in shares of Astera Labs by 117.7% in the 3rd quarter. Liontrust Investment Partners LLP now owns 67,504 shares of the company’s stock valued at $24,029,000 after acquiring an additional 36,490 shares during the last quarter. Zacks Investment Management purchased a new position in shares of Astera Labs in the 3rd quarter valued at about $3,013,000. Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in shares of Astera Labs during the 3rd quarter worth about $1,389,000. Finally, Kentucky Retirement Systems acquired a new stake in shares of Astera Labs during the 3rd quarter worth about $3,431,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several analysts recently commented on the company. Susquehanna dropped their target price on Astera Labs from $310.00 to $258.00 and set a “neutral” rating on the stock in a report on Wednesday, November 4th. Royal Bank Of Canada decreased their price target on Astera Labs from $500.00 to $400.00 and set an “outperform” rating for the company in a report on Wednesday, November 4th. Zacks Research cut shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 5th. Northland Securities raised shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $315.00 price objective for the company in a report on Wednesday, November 4th. Finally, BMO Capital Markets initiated coverage on shares of Astera Labs in a report on Thursday, November 5th. They issued an “outperform” rating and a $375.00 price target for the company. Twelve equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $325.89.
View Our Latest Analysis on ALAB
About Astera Labs
Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.
Featured Stories
- Five stocks we like better than Astera Labs
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
